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Quinazolinone and Quinazoline 
Derivatives: Synthesis and 
Biological Application
Satyendra Mishra
Abstract
Drug discovery and optimization comprise one of the most significant targets 
in medicinal chemistry. Quinazoline and quinazolinone derivatives and nitrogen-
containing heterocycles have received significant attention due to their widely and 
distinct biopharmaceutical activities. Quinazolines and quinazolinones are consid-
ered as noteworthy chemical for the synthesis of diverse physiological significance 
and pharmacological utilized molecules. Quinazolines are building blocks for about 
150 naturally occurring alkaloids with a broad range of biological activity. The vari-
ous substituted quinazolines and quinazolinones displayed important, for example, 
sedative hypnotics, antibacterial, anti-inflammatory, analgesic, antipsychotic, 
antifungal, antimalarial, anticonvulsant, anti-Parkinsonism, cancer, and other 
activities. This chapter aims to highlight the latest evidence of quinazolinone and 
quinazoline derivatives as a privileged scaffold in medicinal chemistry.
Keywords: quinazoline, quinazolinones, antioxidant and anticancer, antibacterial, 
structure-activity relationship
1. Introduction
Emergence of drug resistance has created a critical and unmet medical require-
ment for the innovation and development of novel classes of antibacterial agents 
[1–4]. Due to the appearance of drug resistance bacterial strains, there is an esca-
lating need for the development of novel antibiotics to treat the resistant bacteria 
stain. Diverse set of biological activities of quinazolinones (fused heterocyclic 
system) such as anti-inflammatory, anticonvulsant, anticancer, antibacterial, 
antifungal, anti-HIV and anti-analgesic [5–16], have encouraged to abundant of 
medicinal chemists to investigate this fused heterocycles as a novel drug molecules. 
Several research groups have successfully investigated and reported the promising 
antimicrobial properties and structure-activity relationships (SAR) of various 
quinazolinone derivatives.
Quinazolines and quinazolinones emerged as a privileged class of nitrogen con-
taining heterocyclic scaffolds; exhibits a broad spectrum of pharmacological activi-
ties, viz. anti-inflammatory, antitubercular, and antiviral activities [17]. Number of 
quinazoline derived compound have been approved as a drug; for example prazosin 
and doxazosine are used to treat benign prostatic hyperplasia and post-traumatic 
stress disorder [18], and erlotinib and gefitinib both are used for the curing of lung 
and pancreatic cancers (Figure 1) [19].
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Several quinazolinone-based drugs including idelalisib and fenquizone have 
been shown to exhibit a broad spectrum of antimicrobial, antitumor, antifun-
gal, and cytotoxic activities [20]. Lapatinib has been displayed to be effective in 
combination therapy for breast cancer [21]. In the recent years, various synthetic 
strategies for the synthesis of quinazolines and quinazolinones derivatives have 
Figure 1. 
Quinazoline and quinazolinone-based drugs.
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been developed to accomplish the budding requirements of medicinal chemist 
[22]. Many research groups have successfully utilized copper catalyzed Ullmann-
type coupling procedures of aryl bromides and benzamidines for the synthesis of 
quinazoline derivatives [23].
2. Synthesis of quinazoline and quinazolinone derivatives
1. Synthesis of 4(3H)-quinazolinone using anthranilic acid or formyl anthranila-
mide [24].
2. Via condensation reaction of 4-chloroanthranilic acid amide with triethyl 
orthoformate, the 7-chloro-substituted derivative has been prepared [25].
3. Quinazolin-4(3H)-one was synthesized by the reaction of anthranilic acid with 
excess formamide at 120°C in an open air. This is also known as Niementowski 
reaction [26].
4. 2-styryl-4(3H)-quinazolinone derivatives were prepared using starting sub-
strate 2-aminobenzonitrile with 3-phenyl cinnamoyl chloride. Under alkaline 
conditions, intramolecular cyclization of cinnamamide derivative was carried 
out to afford 2-styryl-4(3H)-quinazolinone. This procedure was tolerated to a 
wide range of different substituted benzene rings [27].
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5. Reaction of anthranilic acid with ammonium acetate, followed by formamide 
under microwave at 200 W yields the desired 2-substituted-4(3H)-quina-
zolinones products [28].
6. Reaction of anthranilamide with substituted aldehydes or ketones in 2,2,2-tri-
fluoroethanol under reflux condition led to the formation of 2-substituted-
2,3-dihydro-4(1H)-quinazolinones in excellent yields [27].
7. The amino-quinazolin-4(3H)-one was synthesized by means of the reaction of 
the corresponding methyl anthranilate with an excess amount of guanidine in 
ethyl alcohol containing sodium ethoxide in moderate yield [29].
8. 4-Arylaminoquinazolines has vast biological potential as anticancer agents, 
thus there has been great interest in their syntheses. Through the reaction 
of 2-aminobenzonitrile with different substituted anilines and anhydrous 
aluminum chloride, amidines were readily produced. Highest yield of the 
amidine intermediates was obtained, when excess amounts of suitable aniline 
and aluminum chloride were used [30].
9. 2,3-disubstituted-4(3H)-quinazolinone derivatives were prepared through the 
treatment of N-acylanthranilic acid with the appropriate aryl amines in the 
presence of phosphorous oxychloride [31].
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10. Benzoxazinone derivatives are the most widespread intermediates in the 
formation of 2,3-disubstituted quinazolinone derivatives. 2-methyl-4H-
benzo[d][1,3]oxazin-4-one was prepared by refluxing mixture of anthranilic 
acid with acetic anhydride in acetic acid [32].
11. The reaction of 2-aminobenzonitrile with Grignard reagents yields the inter-
mediates. The produced intermediate derivatives were very significant for 
getting many types of quinazoline derivatives. Upon their cyclization with 
acid chlorides, anhydrides, and formates, they formed the corresponding 
quinazoline derivatives in moderate to good yields. This general method for 
the preparation of various 2,4-disubstituted quinazoline derivatives is highly 
flexible and useful [33].
12. As shown in the scheme 2-chloromethyl-4-methyl-quinazoline derivatives 
were synthesized by the reaction 1-(2-amino-phenyl)-ethanone with HCl 
gas in anhydrous condition in presence of chloro acetonitrile to get 2-chloro-
methyl-4-methyl-quinazoline. Subsequently treatment of 2-chloromethyl-
4-methyl-quinazoline with different amine derivative in presence of base 
furnished 2-chloromethyl-4-methyl-quinazoline derivatives [34].
3. Biological activities of quinazolinone and quinazoline derivatives
Subsequently the innovation of quinazoline ring numeral of structural modifica-
tions have been made in order to raise the biological activities such as antitubercular, 
Quinazolinone and Quinazoline Derivatives
6
antihistaminic, analgesic, anticonvulsant, antibacterial, antifungal, and anti-inflam-
matory activity which attracted the interest of medicinal chemists.
Cancerous augmentation is the main reasons of global human mortality. Numerous 
antineoplastic drugs are in the market and the majority of the compounds are under 
Figure 2. 
Anticancer activities of quinazolinone and quinazoline derivatives.
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clinical trials. Studies make known that these antineoplastic drugs have exhibited the 
diverse kinds of side effects, as a result researchers around the world are engaged in the 
designing of more proficient and novel antineoplastic drugs. Recently, quinazoline and 
its derivatives have been considered as a novel class of neoplastic chemotherapeutic 
agents to facilitate activity against diverse tumors. Quinazoline is one of the most 
attractive novel bioactive compounds between all the heterocyclic compounds.
Quinazolinone derivatives, the privileged structures in the field of medicinal 
chemistry not only act as good anticancer agents but also act as good DNA interca-
lates [1, 2]. A systematic report is depicted herein for quinazoline ring. A number of 
quinazolinone and quinazoline derivatives (compounds 1–24) have been reported 
for their various anticancer activities (Figure 2) [35–56].
A series of quinazolinone derived Schiff base derivatives were synthesized and 
evaluated for their in vitro H+/K+-ATPase inhibition. Many quinazolinone derived 
Schiff base exhibited outstanding potency, compared to the reference drug omepra-
zole. Especially, hydroxy and methoxy derivatives were the most potent compounds, 
contributing positively to gastric H+/K+-ATPase inhibition. Preliminary structure-
activity relationship revealed that the compounds 25–30 with electron donating moiety 
(OH, OCH3) were found to be excellent activity and compounds 31–34 with electron 
withdrawing moiety (Cl and NO2) were found to be least antiulcer agents [57].
Quinazolinone derived Schiff base derivatives were also used as novel antioxi-
dants and anti-inflammatory agents. The in vitro antioxidant activities of these 
compounds were evaluated and compared with commercial antioxidants viz. 
ascorbic acid (AA), gallic acid (GA), butylated hydroxytoluene (BHT), (DPPH) 
assay, etc. Data illustrates that quinazolinone derived Schiff base with electron 
donating moiety (OH, OCH3) were found to be excellent antioxidants and com-
pounds with electron withdrawing moiety (Cl, NO2) were found to be excellent 
anti-inflammatory agents [58].
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Plausible pathways induced by inhibitors were assessed by evaluating the 
cytotoxic effect of inhibitors such as 3-(5-chloro-2-hydroxybenzylideneamino)-
2-(5-chloro-2-hydroxyphenyl)-2,3-dihydroquinazolin-41(H)-one (35) and 
3-(5-nitro-2-hydroxybenzylideneamino)-2-(5-nitro-2-hydroxyphenyl)-2,3-dihy-
droquinazolin-4(1H)-one (36) on MCF-7, MDA-MB-231, MCF-10A and WRL-68 
cells. MTT assay results of both the compounds showed significant inhibition of 
MCF-7 cell viability [59].
Azaisatins derivative containing 4(3H) quinazolinones has been designed and 
synthesized and were screened for their potential antimicrobial activities, which 
exhibited some authentic results towards testing organism in vitro and in vivo 
studies. Azaisatins derivatives with –C6H13 (40) display good antimicrobial activity 
compare to other synthesized Azaisatins [60].
Quinazolinone derivatives containing 3-acrylamino motifs were screened for 
antifungal activities against four phytopathogenic fungi by minimum inhibitory 
concentration (MIC) method. Compounds 41–43, exhibited broad antifungal 
activities and substituent’s play important role in activities [61].
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A series of novel quinazolinone derivatives containing an amino substituted 
amino moiety were reported for their cytotoxic and antibacterial activities. Among 
the synthesized compounds 47–49 showed broad-spectrum cytotoxic activities 
giants at least four cancer cell lines at low concentrations. Compounds 44–46 
exhibited good to moderate antibacterial activities against gram positive and gram 
negative bacterial strains [62].
Quinazolinone derivatives manipulate mutant p53 proteins and their corre-
sponding cellular response in p53 mutant cancer cells. Compounds 50 and 51 exhib-
ited promising broad-spectrum anti-cancer effects, while 50 demonstrated selective 
and exclusive inhibition activity in p53 mutant cancer cell lines. Quinazolinone 
derivatives 50 dictate mutant p53 function for apoptotic cell death [63].
2-(4-bromophenyl)-quinazolin-4(3H)-one (52A) and 2-(4-chlorophenyl)-
quinazolin-4(3H)-one (52B) exhibited α-glucosidase inhibitory activity with 
IC50 values of 12.5 ± 0.1 lM and 15.6 ± 0.2 lM, respectively. Spectroscopy methods 
were performed to analyze the inhibitory mechanisms of both compounds on 
α-glucosidase. The outcome of inhibitory mechanism disclosed, that the com-
pounds, inhibited α-glucosidase in reversible and non-competitive manner. Briefly, 
the quinazolinone derivatives could be potentially promising candidates in the field 
of anti-diabetic agents development [64].
RAD51 is an essential component of the homologous recombination DNA 
repair pathway and is over expressed in drug-resistant cancers, including aggres-
sive triple negative breast cancer (TNBC). Structure activity relationships study of 
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quinazolinone derivatives showed that inhibitor (53) as a novel RAD51 inhibitor 
exhibited up to 15-fold enhanced inhibition of cell growth. Furthermore, inhibitors 
17 notably hamper TNBC cell sensitivity to DNA damage. This would be potentially 
targeted therapy for cancer treatment [65].
A series of novel carbazolyloxy phenylquinazoline derivatives have been 
developed as angiotensin converting enzyme (ACE) inhibitors. Amongst them 
compounds (54–56) showed maximum inhibitory potency in enzyme based assays. 
The most potent (54–56) compounds have common active site with the Lisinopril 
binding site [66].
Compounds, 3-(5-chloro-2-hydroxybenzylideneamino)-2-(5-chloro-2- 
hydroxyphenyl)-2,3-dihydroquinazolin-41(H)-one (57) and 3-(5-nitro-2 
-hydroxybenzylideneamino)-2-(5-nitro-2-hydroxyphenyl)-2,3-dihydroquinazolin-
4(1H)-one (58) were screened for their cytotoxic effect on MCF-7, MDA-MB-231, 
MCF-10A and WRL-68 cells. The mechanism involved in apoptosis, induced by 
compound 57 and 58 was also evaluated. Additionally, caspase-8 illustrates sig-
nificant potency, followed by inhibition of NF-κB activation in 57- and 58-treated 
MCF-7 cells. The results indicated that A and B could induce apoptosis via a mecha-
nism that involves either extrinsic or intrinsic pathways [59].
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Substituted quinazolinones derivatives were tested for their antimicrobial 
activity against Gram-negative bacteria and Gram-positive bacteria. Among the 
prepared products, 3-benzyl-2-(4-chlorophenyl) quinazolin-4(3H)-one (3a) 
was found to exhibits the most potent in vitro anti-microbial activity against 
Staphylococcus aureus.
4. Conclusions
Over the past few decades, more effort has been established into searching of 
better drugs with minimal side effects. Herein number versatile synthetic proce-
dures are discussed for the synthesis of quinazolinone and quinazoline derivatives. 
In general, quinazolinone and quinazoline derivatives are known to possess wide 
range of activities. A specific activity depends on the substituent present at an 
appropriate position of quinazoline. The study of natural and synthetic quinazoli-
none and quinazoline derivatives identified as potentially promising candidates for 
developing as novel therapeutic agents. There is possibility for further development 
as new research into study of medicinal chemistry related field.
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